GRM5 and Parkinson disease: Given the abundant expression of mGluR5 in brain regions involved in AD and PD such as the frontal cortex, limbic system, and caudoputamen [37], it has been proposed that alterations in mGluR5 may be involved in the pathogenesis of AD [32] and PD [33], [34], [35], [36].